{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T13:56:14Z","timestamp":1760622974999},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMW","doi-asserted-by":"publisher","award":["836031012"],"award-info":[{"award-number":["836031012"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["contemporaryclinicaltrials.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.cct.2016.01.007","type":"journal-article","created":{"date-parts":[[2016,1,26]],"date-time":"2016-01-26T23:00:35Z","timestamp":1453849235000},"page":"228-234","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["A randomized controlled trial on the benefits and respiratory adverse effects of morphine for refractory dyspnea in patients with COPD: Protocol of the MORDYC study"],"prefix":"10.1016","volume":"47","clinical-trial-number":[{"clinical-trial-number":"nct02429050","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"C.A.","family":"Verberkt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.H.J.","family":"van den Beuken-van Everdingen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.M.E.","family":"Franssen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.D.","family":"Dirksen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.G.A.","family":"Schols","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.F.M.","family":"Wouters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.J.A.","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cct.2016.01.007_bb0010","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/S0140-6736(06)68770-9","article-title":"Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data","volume":"367","author":"Lopez","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.cct.2016.01.007_bb0015","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1089\/jpm.2010.0479","article-title":"Symptoms, comorbidities, and health care in advanced chronic obstructive pulmonary disease or chronic heart failure","volume":"14","author":"Janssen","year":"2011","journal-title":"J. Palliat. Med."},{"key":"10.1016\/j.cct.2016.01.007_bb0020","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1183\/09031936.94.07071342","article-title":"Chronic lung diseases and the perception of breathlessness: a clinical perspective","volume":"7","author":"Burdon","year":"1994","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.cct.2016.01.007_bb0025","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1136\/thorax.57.11.939","article-title":"A systematic review of the use of opioids in the management of dyspnoea","volume":"57","author":"Jennings","year":"2002","journal-title":"Thorax"},{"key":"10.1016\/j.cct.2016.01.007_bb0030","doi-asserted-by":"crossref","first-page":"g7617","DOI":"10.1136\/bmj.g7617","article-title":"The management of chronic breathlessness in patients with advanced and terminal illness","volume":"349","author":"Ekstrom","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.cct.2016.01.007_bb0035","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jpainsymman.2010.11.021","article-title":"Once-daily opioids for chronic dyspnea: a dose increment and pharmacovigilance study","volume":"42","author":"Currow","year":"2011","journal-title":"J. Pain Symptom Manag."},{"key":"10.1016\/j.cct.2016.01.007_bb0040","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1164\/rccm.200605-587ST","article-title":"An official American Thoracic Society clinical policy statement: palliative care for patients with respiratory diseases and critical illnesses","volume":"177","author":"Lanken","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.cct.2016.01.007_bb0045","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1378\/chest.09-1543","article-title":"American College of Chest Physicians consensus statement on the management of dyspnea in patients with advanced lung or heart disease","volume":"137","author":"Mahler","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.cct.2016.01.007_bb0050","doi-asserted-by":"crossref","DOI":"10.1177\/1479972315571926","article-title":"Attitudes toward opioids for refractory dyspnea in COPD among Dutch chest physicians","author":"Janssen","year":"2015","journal-title":"Chron. Respir. Dis."},{"key":"10.1016\/j.cct.2016.01.007_bb0055","doi-asserted-by":"crossref","first-page":"E497","DOI":"10.1503\/cmaj.111758","article-title":"Perspectives of patients, family caregivers and physicians about the use of opioids for refractory dyspnea in advanced chronic obstructive pulmonary disease","volume":"184","author":"Rocker","year":"2012","journal-title":"CMAJ"},{"key":"10.1016\/j.cct.2016.01.007_bb0060","first-page":"e401","article-title":"Using opioids to treat dyspnea in advanced COPD: attitudes and experiences of family physicians and respiratory therapists","volume":"58","author":"Young","year":"2012","journal-title":"Can. Fam. Physician"},{"key":"10.1016\/j.cct.2016.01.007_bb0065","unstructured":"World Health Organisation. WHO Definition of Palliative Care. http:\/\/www.who.int\/cancer\/palliative\/definition\/en\/Accessed2015\/09\/17."},{"key":"10.1016\/j.cct.2016.01.007_bb0070","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1136\/bmj.327.7414.523","article-title":"Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea","volume":"327","author":"Abernethy","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.cct.2016.01.007_bb0075","doi-asserted-by":"crossref","first-page":"610921","DOI":"10.1155\/2012\/610921","article-title":"Effect of nebulized morphine on dyspnea of mustard gas-exposed patients: a double-blind randomized clinical trial study","volume":"2012","author":"Shohrati","year":"2012","journal-title":"Pulm. Med."},{"key":"10.1016\/j.cct.2016.01.007_bb0080","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1164\/ajrccm.157.6.9711061","article-title":"The effect of sustained-release morphine on breathlessness and quality of life in severe chronic obstructive pulmonary disease","volume":"157","author":"Poole","year":"1998","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.cct.2016.01.007_bb0085","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1513\/AnnalsATS.201501-034OC","article-title":"Effects of opioids on breathlessness and exercise capacity in chronic obstructive pulmonary disease. A systematic review","volume":"12","author":"Ekstrom","year":"2015","journal-title":"Ann. Am. Thorac. Soc."},{"key":"10.1016\/j.cct.2016.01.007_bb0090","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/imj.12857","article-title":"Management of refractory breathlessness with morphine in patients with chronic obstructive pulmonary disease","volume":"45","author":"Smallwood","year":"2015","journal-title":"Intern. Med. J."},{"key":"10.1016\/j.cct.2016.01.007_bb0095","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jpainsymman.2011.05.007","article-title":"Inhaled fentanyl citrate improves exercise endurance during high-intensity constant work rate cycle exercise in chronic obstructive pulmonary disease","volume":"43","author":"Jensen","year":"2012","journal-title":"J. Pain Symptom Manag."},{"key":"10.1016\/j.cct.2016.01.007_bb0100","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1183\/09031936.93.04080926","article-title":"Oral diamorphine: lack of effect on dyspnoea and exercise tolerance in the \u201cpink puffer\u201d syndrome","volume":"4","author":"Eiser","year":"1991","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.cct.2016.01.007_bb0105","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1164\/ajrccm\/139.1.126","article-title":"Effects of oral morphine on breathlessness and exercise tolerance in patients with chronic obstructive pulmonary disease","volume":"139","author":"Light","year":"1989","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.cct.2016.01.007_bb0110","doi-asserted-by":"crossref","first-page":"g445","DOI":"10.1136\/bmj.g445","article-title":"Safety of benzodiazepines and opioids in very severe respiratory disease: national prospective study","volume":"348","author":"Ekstrom","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.cct.2016.01.007_bb0115","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1183\/09031936.00139812","article-title":"Opioids for chronic refractory breathlessness: patient predictors of beneficial response","volume":"42","author":"Johnson","year":"2013","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.cct.2016.01.007_bb0120","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1164\/rccm.201111-2042ST","article-title":"An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea","volume":"185","author":"Parshall","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.cct.2016.01.007_bb0125","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1136\/thx.54.7.581","article-title":"Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease","volume":"54","author":"Bestall","year":"1999","journal-title":"Thorax"},{"key":"10.1016\/j.cct.2016.01.007_bb0130","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0140-6736(08)60048-3","article-title":"Integration of pulmonary rehabilitation in COPD","volume":"371","author":"Spruit","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.cct.2016.01.007_bb0135","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1164\/rccm.201309-1634ST","article-title":"An official American Thoracic Society\/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation","volume":"188","author":"Spruit","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.cct.2016.01.007_bb0140","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jpainsymman.2013.01.011","article-title":"Clinically important differences in the intensity of chronic refractory breathlessness","volume":"46","author":"Johnson","year":"2013","journal-title":"J. Pain Symptom Manag."},{"key":"10.1016\/j.cct.2016.01.007_bb0145","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1136\/thx.2010.156372","article-title":"The COPD Assessment Test (CAT): response to pulmonary rehabilitation. A multicentre, prospective study","volume":"66","author":"Dodd","year":"2011","journal-title":"Thorax"},{"key":"10.1016\/j.cct.2016.01.007_bb0150","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1183\/09031936.00102509","article-title":"Development and first validation of the COPD Assessment Test","volume":"34","author":"Jones","year":"2009","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.cct.2016.01.007_bb0155","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jamda.2011.06.009","article-title":"Predicting outcomes from 6-minute walk distance in chronic obstructive pulmonary disease","volume":"13","author":"Spruit","year":"2012","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"10.1016\/j.cct.2016.01.007_bb0160","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1046\/j.1440-172X.2002.00384.x","article-title":"Further psychometric testing of the Dutch Care Dependency Scale on two different patient groups","volume":"8","author":"Dijkstra","year":"2002","journal-title":"Int. J. Nurs. Pract."},{"key":"10.1016\/j.cct.2016.01.007_bb0165","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1532-5415.1991.tb01616.x","article-title":"The timed \u201cUp & Go\u201d: a test of basic functional mobility for frail elderly persons","volume":"39","author":"Podsiadlo","year":"1991","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.cct.2016.01.007_bb0170","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/0269216307076398","article-title":"Which measurement scales should we use to measure breathlessness in palliative care? A systematic review","volume":"21","author":"Dorman","year":"2007","journal-title":"Palliat. Med."},{"key":"10.1016\/j.cct.2016.01.007_bb0175","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1378\/chest.11-1087","article-title":"Reliability and validity of the Multidimensional Dyspnea Profile","volume":"141","author":"Meek","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.cct.2016.01.007_bb0180","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1183\/09031936.00038914","article-title":"Multidimensional Dyspnea Profile: an instrument for clinical and laboratory research","volume":"45","author":"Banzett","year":"2015","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.cct.2016.01.007_bb0185","first-page":"242","article-title":"Development and testing of the Pulmonary Functional Status and Dyspnea Questionnaire (PFSDQ)","volume":"23","author":"Lareau","year":"1994","journal-title":"Heart Lung"},{"key":"10.1016\/j.cct.2016.01.007_bb0190","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0147-9563(98)90003-6","article-title":"Development and testing of the modified version of the Pulmonary Functional Status and Dyspnea Questionnaire (PFSDQ-M)","volume":"27","author":"Lareau","year":"1998","journal-title":"Heart Lung"},{"key":"10.1016\/j.cct.2016.01.007_bb0195","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1471-2288-14-78","article-title":"Measuring health-related quality of life in chronic obstructive pulmonary disease: properties of the EQ-5D-5L and PROMIS-43 short form","volume":"14","author":"Lin","year":"2014","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.cct.2016.01.007_bb0200","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J. Chronic Dis."},{"key":"10.1016\/j.cct.2016.01.007_bb0205","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/sleep\/17.8.703","article-title":"Sleepiness in different situations measured by the Epworth Sleepiness Scale","volume":"17","author":"Johns","year":"1994","journal-title":"Sleep"},{"key":"10.1016\/j.cct.2016.01.007_bb0210","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1378\/chest.11-3035","article-title":"Mild cognitive impairment in moderate to severe COPD: a preliminary study","volume":"142","author":"Villeneuve","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.cct.2016.01.007_bb0215","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S2213-2600(14)70001-3","article-title":"Minimum clinically important difference for the COPD Assessment Test: a prospective analysis","volume":"2","author":"Kon","year":"2014","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.cct.2016.01.007_bb0220","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1016\/j.rmed.2007.07.003","article-title":"Extra-pulmonary features in COPD patients entering rehabilitation after stratification for MRC dyspnea grade","volume":"101","author":"Spruit","year":"2007","journal-title":"Respir. Med."},{"key":"10.1016\/j.cct.2016.01.007_bb0225","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/00005650-199711000-00002","article-title":"Modeling valuations for EuroQol health states","volume":"35","author":"Dolan","year":"1997","journal-title":"Med. Care"},{"key":"10.1016\/j.cct.2016.01.007_bb0230","series-title":"Richtlijn Voor Het Uitvoeren Van Economische Evaluaties in de Gezondheidszorg","author":"Nederland","year":"2015"},{"key":"10.1016\/j.cct.2016.01.007_bb0235","doi-asserted-by":"crossref","DOI":"10.3310\/hta8360","article-title":"Review of guidelines for good practice in decision-analytic modelling in health technology assessment","volume":"8","author":"Philips","year":"2004","journal-title":"Health Technol. Assess."},{"key":"10.1016\/j.cct.2016.01.007_bb0240","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1089\/jpm.2007.9912","article-title":"Can we predict which patients with refractory dyspnea will respond to opioids?","volume":"10","author":"Currow","year":"2007","journal-title":"J. Palliat. Med."},{"key":"10.1016\/j.cct.2016.01.007_bb0245","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1378\/chest.109.4.975","article-title":"Effect of 30mg of morphine alone or with promethazine or prochlorperazine on the exercise capacity of patients with COPD","volume":"109","author":"Light","year":"1996","journal-title":"Chest"},{"key":"10.1016\/j.cct.2016.01.007_bb0250","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1056\/NEJM198112313052703","article-title":"Effects of dihydrocodeine, alcohol, and caffeine on breathlessness and exercise tolerance in patients with chronic obstructive lung disease and normal blood gases","volume":"305","author":"Woodcock","year":"1981","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cct.2016.01.007_bb0255","doi-asserted-by":"crossref","first-page":"906","DOI":"10.7326\/0003-4819-119-9-199311010-00007","article-title":"Subcutaneous morphine for dyspnea in cancer patients","volume":"119","author":"Bruera","year":"1993","journal-title":"Ann. Intern. Med."}],"container-title":["Contemporary Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714416300076?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714416300076?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T16:38:27Z","timestamp":1692203907000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551714416300076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":50,"alternative-id":["S1551714416300076"],"URL":"https:\/\/doi.org\/10.1016\/j.cct.2016.01.007","relation":{},"ISSN":["1551-7144"],"issn-type":[{"value":"1551-7144","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A randomized controlled trial on the benefits and respiratory adverse effects of morphine for refractory dyspnea in patients with COPD: Protocol of the MORDYC study","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cct.2016.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}